2 reports

In this trial, ## patients were randomized to receive one of three treatments: ## mg ITI-##, ## mg ITI-##, or placebo in a ##:##:## ratio.

  • Clinical Chemistry
  • Healthcare
  • Northern Europe
  • United Kingdom
  • GE Healthcare Limited

< P/ > INTEREST ON THE NOTES IS PAYABLE SEMI-ANNUALLY ON FEBRUARY ## AND AUGUST ##, COMMENCING AUGUST ##, 2015.

  • Clinical Chemistry
  • Medical Device
  • North America
  • United States
  • Illumina, Inc.